Dermatology

Mark J. Eliason, M.D.

Mark J. Eliason, M.D.Instructor of Dermatology

  • B.S., 1999, Brigham Young University
  • M.D., 2003, University of California School of Medicine, Irvine, California
  • Internship in Internal Medicine, 2003-2004, University of Utah School of Medicine, Salt Lake City, Utah
  • Post Doctoral Research Fellowship in Familial Melanoma, 2004-2006, Huntsman Cancer Institute, Salt Lake City, Utah
  • Residency in Dermatology, 2006-2009, University of Utah School of Medicine

Clinical and Research Interests

  • General Dermatology
  • Melanoma and skin cancer
  • Urticaria

Selected Publications

  • Wilson LH, Eliason MJ, Leiferman KM, Hull CM, Powell DL. Treatment of refractory chronic urticaria with tumor necrosis factor-α inhibitors (Submitted to Arch Derm 2008)
  • Eliason MJ, Bowen GM, Bowen AR, Hazzard L, Samlowski WE. Primary Treatment of Verrucous Carcinoma of the Penis with 5-fluorouracil, cis-diamino-dichloro platinum and Radiation Therapy (In Press, Arch Derm)
  • Eliason MJ, Hansen, CB, Hart M, Chen B, Bowen G, Florell SR, Harris RM, Cannon-Albright LA, Swinyer L, Leachman S. Multiple primary melanomas in a CDKN2A mutation carrier exposed to ionizing radiation. Arch Derm 2007 Nov. 143(11) 1409-1412.
  • Jackson R, Eliason MJ, Larson AA, Bolognia J, Leachman SA. Management of Melanoma during Pregnancy, Dermatol Nurs. 2007 Apr; 19(2): 145-52, 161.
  • Larson AA, Leachman SA, Eliason MJ, Cannon-Albright LA. Population-based assessment of non-melanoma cancer risk in relatives of cutaneous melanoma probands. J Invest Dermatol. 2007 Jan;127(1):183-8.
  • Eliason MJ, Larson AA, Florell SR, Zone JJ, Cannon-Albright LA, Samlowski WE, Leachman SA. Population-based prevalence of CDKN2A mutations in Utah melanoma families. J Invest Dermatol. 2006 Mar; 126(3):660-6.